nt-i7
Showing 1 - 5 of 5
Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)
Recruiting
- Progressive Multifocal Leukoencephalopathy
- NT-I7
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 2, 2022
Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) Trial in Poland, Spain, United States (NT-I7,
Active, not recruiting
- Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
- NT-I7
- Nivolumab
-
Louisville, Kentucky
- +5 more
Dec 7, 2022
Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,
Recruiting
- Any Advanced Solid Tumors
- +6 more
- NT-I7
- Pembrolizumab
-
Tampa, Florida
- +7 more
Jul 13, 2022
COVID-19, SARS-CoV-2 Trial (NT-I7, Placebo, Blood for research purposes)
Withdrawn
- COVID-19
- SARS-CoV-2
- NT-I7
- +5 more
- (no location specified)
Jul 29, 2021